Walgreens removes purchase limits on children’s fever meds
Bruce Bennett/Getty Images News


Pharmacy retailer Walgreens (NASDAQ:WBA) announced Monday that the company would no longer limit the online purchases of over-the-counter pediatric fever-reducing products due to improved supplies.
In December, Walgreens (WBA) and rival CVS Health (CVS) were forced to limit the purchases of childrenâs pain-relief products and fever reducers as COVID-19 worsened the flu season, driving up demand for medicines amid supply constraints.

Walgreens (WBA) had set the purchase limits at six OTC pediatric fever reducers per online transaction to prevent excessive purchasing.
âWalgreens has worked diligently with our suppliers to ensure we have enough supply to meet customer demand nationwide,â the company said.
âDue to the improved in-stock conditions of over-the-counter pediatric fever-reducing products, we have removed the online only purchase limit,â Walgreens (WBA) added.
Read: Seeking Alpha contributor Bela Lakos issues a Buy rating on Walgreens (WBA) due to its track record of dividend payments.